Dear Friends and Colleagues:

We are pleased to share with you the spring edition of the Skirball Medtech Quarterly. In this issue, we highlight the emerging field of flexible electronics—an area of development that promises to expand the capabilities of the catheter-based technological field. Also included is an update of the most relevant data presented on renal denervation and TAVR at ACC this year. Additionally, the latest advances and globally relevant news in interventional innovation are presented in our “Drivers and Movers” section. 

Thanks to those of you who have inspired the development of this quarterly; we greatly appreciate the ongoing feedback. We welcome your comments directly or through our    page. 

 

All the best, 
Juan F. Granada, MD
Executive Director and Chief Scientific Officer 
CRF Skirball Center for Innovation
jgranada@crf.org

 

 

Featured Technology

Flexible electronic medical devices continue to take shape among leaders of healthcare innovation with their ongoing novel wearable technologies

Share:  

Stretchable electronic innovation expanding into catheter-based therapies and beyond

Share:  

 

 

 

Technology Evolution: Publications & Presentations

ACC 2014 Late-Breaking Trials Wrap-Up: Focus on Renal Denervation Webcast

Share:  

ACC 2014 Late Breaking Trials Wrap-Up: Focus on TAVR

Share:  

Novel minimally invasive heart device opens further possibilities for heart failure patients (video)

Share:  

Past Q&A reveals inspiration of silicon elasticity in the evolving space of stretchable electronics

Share:  

Key opinion leaders discuss a snapshot of innovation and the possibilities for the next revolution in interventional cardiology (video)

Share:  

 

 

 

Drivers & Movers

CFDA tightens regulations governing medical devices while remaining sensitive to innovation growth in China

Share:  

DCB shows superiority over PTA in patency and reinterventions and is an impactful component in treating PAD

Share:  

Collaboration with the FDA to improve medical technology reviews and the harmonization of global regulation are among the priorities of AdvaMed’s new chairman.

Share:  

Recent controversial renal denervation developments will support innovation in the long term by providing therapy insight and a refocus to the science and demonstrating the value of conducting rigorous trials

Share:  

 

Interventional Innovation Program at TCT 2014

Forthcoming Emerging Cardiovascular Technologies TCT 2014 Innovation Competition

Share: